DR Adel Gassab Mohammed

Prof. Dr. DR Adel Gassab Mohammed

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
DMDR Adel Gassab Mohammed
DR Adel Gassab Mohammed
AMAbbas Ali Mansour
Abbas Ali Mansour
JAJawad Hassan Ahmed
Jawad Hassan Ahmed
The aim of the present study was to investigate the effects of exogenous glucocorticoids (GCs), a potent cause of male hypogonadism, on the function of the hypothalamic‑­pituitary‑gonadal axis, and to determine their secondary effects in male patients. The present study was a case‑controlled study conducted in Basrah, Iraq. Of the 152 participants who met the inclusion criteria, 100 patients used different types of GCs. Of these 100 patients, 57 patients (57%) were current GC users, and 43 patients (43%) were not currently using GCs (had not used GCs in the past 30 days). The control group was comprised of 52 men (34.21%), considered as healthy participants, although 7 men (13.65%) were biochemically diagnosed with hypogonadism. Current GC exposure significantly decreased the total and free testosterone levels, whereas previous GC exposure increased estradiol (E2) levels, with the 31 patients on oral dexamethasone (cumulative dose, 18.9 mg) exhibiting a 7.5‑fold increased risk of being diagnosed with hypogonadism. For previous GC users, a significant increase in the E2 level was observed, whereas all other gonadal hormonal levels were within normal reference ranges, including the total and free testosterone levels. The total cumulative dose of equivalent GCs was 240 mg, which resulted in a decrease in total testosterone levels, and subsequent hypogonadism. Oral dexamethasone at a lower total cumulative dose resulted in hypogonadism.

6 April 2020 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
IZIbrahim Abbood Zaboon
Ibrahim Abbood Zaboon
HAHaider Ayad Alidrisi
Haider Ayad Alidrisi
IHIbrahim Hani Hussein
Ibrahim Hani Hussein
MAMajid Alabbood
Majid Alabbood
NANassar Taha Yaseen Alibrahim
Nassar Taha Yaseen Alibrahim
AMAbbas Ali Mansour
Abbas Ali Mansour
Fasting the month of Ramadan should be achieved by every pubescent Muslim unless they have an excuse. Fasting involves complete abstinence of oral intake th ...

6 April 2018 in F1000Research
Verified
Journal Article
Open access
PDF file
AMAbbas Ali Mansour
Abbas Ali Mansour
AAAli Hussain Ali Alhamza
Ali Hussain Ali Alhamza
AAAmmar Mohammed Saeed Abdullah Almomin
Ammar Mohammed Saeed Abdullah Almomin
IZIbrahim Abbood Zaboon
Ibrahim Abbood Zaboon
NANassar Taha Yaseen Alibrahim
Nassar Taha Yaseen Alibrahim
IHIbrahim Hani Hussein
Ibrahim Hani Hussein
Background: Sellar and parasellar region lesions spectrum includes a wide variety of diseases. This study aimed at providing a comprehensive overview of such lesions in patients from Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah (Southern Iraq). Methods:Retrospective data analysis from FDEMC for the period January 2012 through June 2017. We included all patients with sellar and parasellar region lesions who received a MRI scan on their pituitary region Results:The total enrolled patients were 232 (84 men and 148 women),with age range 15-75 years.Pituitary disease and adenoma were more common among women. Those with macroadenoma were older than those with microadenoma, with nearly equal gender prevalence of macroadenoma. Pituitary adenoma constituted the bulk of pituitary disease in this setting (67.2%). Growth hormone secreting adenoma were the most common adenoma seen in 41.0%, followed by clinically non-functioning pituitary adenoma (NFPA) in 31.4% and prolactinoma in 26.9%. About 64.8% of pituitary adenoma was macroadenoma. Macroadenoma was seen in 73.4% of growth hormone secreting adenoma (acromegaly), 61.2% in NFPA and 62.0% of prolactinom a(of them six were giant prolactinoma). Conclusion: Pituitary adenoma constituted the bulk of sellar and parasellar region lesions, growth hormone secreting adenoma is the the most common adenoma followed by NFPA and prolactinoma due to referral bias. A change in practice of adenoma treatment is needed.

22 June 2018 in F1000Research
Verified
Journal Article
Open access
PDF file
AMAbbas Ali Mansour
Abbas Ali Mansour
AAAli Hussain Ali Alhamza
Ali Hussain Ali Alhamza
AAAmmar Mohammed Saeed Abdullah Almomin
Ammar Mohammed Saeed Abdullah Almomin
IZIbrahim Abbood Zaboon
Ibrahim Abbood Zaboon
NANassar Taha Yaseen Alibrahim
Nassar Taha Yaseen Alibrahim
IHIbrahim Hani Hussein
Ibrahim Hani Hussein
Background:Pituitary disorders spectrum includes a wide variety of diseases.This study aimed at a comprehensive description of such disorders for patients from Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah (Southern Iraq). Methods: Retrospective data analysis of FDEMC for the period from January 2012 through June 2017. We included all patients with pituitary disorders who have MRI pituitary. Results: The pituitary disorders were more common among women. Those with macroadenoma were older than those with microadenoma with nearly equal gender prevalence of macroadenoma. Pituitary adenoma constituted the bulk of pituitary disorders in this registry (67.2%). Growth hormone secreting adenoma were the commonest adenoma seen in 41.0% followed by clinically non-functioning pituitary adenoma(NFPA)in 31.4% and prolactinoma in 26.9%. About 64.8% of pituitary adenoma was macroadenoma. Macroadenoma was seen in 73.4 % of growth hormone secreting adenoma, 61.2% in NFPA and 62.0% of prolactinoma (of them six were giant prolactinoma) Conclusion: Pituitary adenoma constituted the bulk of pituitary disorders in Basrah, growth hormone secreting adenoma is the commonest adenoma followed by NFPA and prolactinoma due to referral bias. A change in practice of pituitary adenoma treatment is needed.

30 December 2021 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
IHIbrahim Hani Hussein
Ibrahim Hani Hussein
AMAbbas Ali Mansour
Abbas Ali Mansour
HNHussein Ali Nwayyir
Hussein Ali Nwayyir
AAAmmar Mohammed Saeed Abdullah Almomin
Ammar Mohammed Saeed Abdullah Almomin
NANassar Taha Yaseen Alibrahim
Nassar Taha Yaseen Alibrahim
AAAli Hussain Ali Alhamza
Ali Hussain Ali Alhamza
Background: People from our region need a higher dose of vitamin D to maintain their serum 25(OH)D levels at concentrations greater than 20 ng/mL. This study aimed to obtain real data on vitamin D status in Basrah. Methods: Retrospective data analysis of patients seen over 2 years from May 2017 to the end of May 2019 at the Faiha Specialized Diabetes, Endocrine and Metabolism Centre (FDEMC) in Basrah, a tertiary referring center of southern Iraq. Results: The cohort included 3692 persons. Vitamin D deficiency was evident among 62.5% of the studied persons (66.5% of women and 48.7% of men). Univariate analysis for factors associated with vitamin D deficiency found it was significantly associated with female sex (OR, 2.095; 95% CI, 1.793 to 2.448; P<0.0001), age less than 44 years (OR, 2.6; 95% CI, 2.328 to 3.065; P<0.0001), nonmarried status (including single, widow and divorced) (OR, 0.768; 95% CI, 0.656 to 0.900; P<0.0001), nulliparous or unmarried status (OR, 0.684; 95% CI, 0.583 to 0.803; P<0.0001), housewife status (OR, 0.806; 95% CI, 0.673 to 0.967; P=0.020), and rural status (OR, 1.195; 95% CI, 1.034 to 1.382; P=0.016). No significant association was found between vitamin D deficiency and BMI. In multivariate logistic regression analyses, only female sex (OR, 0.513; 95% CI, 0.437 to 0.603; P<0.0001) and age less than 44 years (OR, 2.662; 95% CI, 2.252 to 3.147; P<0.0001), nulliparous or unmarried (OR, 0.814; 95% CI, 0.680 to 0.973; P=0.024) and rural residency (OR, 0.773; 95% CI, 0.647 to 0.924; P<0.0001) remained significantly associated. Conclusion: Women, a younger age, nulliparous, and a rural residency were associated with vitamin D deficiency.

24 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
DMDR Adel Gassab Mohammed
DR Adel Gassab Mohammed
RARiyadh Khion Abdulah
Riyadh Khion Abdulah
SOSamih Abed Odhaib
Samih Abed Odhaib
DADheya Kadhim AlWaeli
Dheya Kadhim AlWaeli
MAMahmood Thamer Altemimi
Mahmood Thamer Altemimi
Type 2 diabetes mellitus (T2DM) poses a significant economic and clinical burden. Clinical inertia is defined as the failure of healthcare providers to modify therapy in the presence of clear indications. This study aimed to identify patient opinions on insulin to understand the barriers preventing type 2 diabetes patients from initiating insulin treatment when recommended by their physician. This cross-sectional observational study included 671 individuals with poorly controlled T2DM and HbA1c levels exceeding 10%. These patients required either the initiation or escalation of their existing insulin therapy. The participants were referred to Thi-Qar Specialized Diabetes Endocrine and Metabolism Center (TDEMC) for consultation between January 2022 and July 2022.Results: During discussions between the researcher (clinician) and the inadequately controlled T2DM patients, the primary reasons for refusing insulin therapy were identified. These reasons included fear of injections, the belief that insulin induces dependence and is a last resort, concerns about hypoglycemia and complications, cost, difficulty in computing doses, social stigma, inconvenience and disruption to life and work, storage challenges, fear of weight gain, dependence on others, and lack of confidence.The study concludes that the clinical barriers faced by individuals who refuse the initiation of insulin therapy are diverse. The most common belief among the patients was that insulin leads to dependence (38%), while the smallest percentage cited a lack of confidence in insulin as an effective treatment for lowering hyperglycemia.